| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Feld Michael | EVP, CRO & Pres. Life Sciences | C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES | Donna Kalazdy, by power of attorney from Michael Feld | 01 Dec 2025 | 0002034349 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Common Stock | Award | $0 | +8,829 | +107% | $0.000000 | 17,074 | 26 Nov 2025 | Direct | F1 |
| transaction | BDX | Common Stock | Tax liability | $0 | -419 | -2.5% | $0.000000 | 16,655 | 26 Nov 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
| F2 | Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. |